Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16109111 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
"Completeness of Response" Following Treatment With Treximet™ for Migraine
Condition: Migraine
Intervention: Drug: sumatriptan succinate 85 mg/naproxen sodium 500 mg (Treximet)

Indicates status has not been verified in more than two years